MYGN icon

Myriad Genetics
MYGN

Overview Fund Activity

223 hedge funds and large institutions have $1.7B invested in Myriad Genetics in 2016 Q3 according to their latest regulatory filings, with 32 funds opening new positions, 91 increasing their positions, 72 reducing their positions, and 57 closing their positions.

Holders
223
Holders Change
-29
Holders Change %
-11.51%
% of All Funds
5.96%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
32
Increased
91
Reduced
72
Closed
57
Calls
$5.41M
Puts
$7.99M
Net Calls
-$2.58M
Net Calls Change
+$15.1M

Top Buyers

1
Acadian Asset Management
1
Acadian Asset Management
Massachusetts
$57.2M
2
Renaissance Technologies
2
Renaissance Technologies
New York
$60.3M
3
Citadel Advisors
3
Citadel Advisors
Florida
$28.2M
4
Neuberger Berman Group
4
Neuberger Berman Group
New York
$24.2M
5
NTC
5
North Tide Capital
Massachusetts
$20.6M

Top Sellers

1
IAM
1
Iridian Asset Management
Connecticut
$0
2
Capital Research Global Investors
2
Capital Research Global Investors
California
$91M
3
SCM
3
Scopia Capital Management
New York
$75.3M
4
Baillie Gifford & Co
4
Baillie Gifford & Co
United Kingdom
$215M
5
RA
5
Royce & Associates
New York
$1.86M
Name Holding Trade Value Shares
Change 		Shares
Change %
Northwestern Mutual Wealth Management
276
Northwestern Mutual Wealth Management
Wisconsin
– -$22K -728 Closed
FIB
277
First Interstate Bank
Montana
– -$14K -451 Closed
PAM
278
Paradigm Asset Management
New York
– -$13.8K -450 Closed
Fifth Third Bancorp
279
Fifth Third Bancorp
Ohio
– -$3K -91 Closed
CCA
280
Checchi Capital Advisers
California
– -$2K -59 Closed
8 9 10 11
12